Cardiac Biomarkers in Pediatric Cardiomyopathy
To determine the ability of established and novel cardiac biomarkers to predict short- and long-term outcomes.
Are you Eligible? (Inclusion Criteria)
Diagnosis at 18 years of age or less with dilated, hypertrophic, or restrictive cardiomyopathy.
Specialty Area(s)
Cardiac
Pediatric Surgery
Trial Location
NYP/Columbia
New York, NY 10032
United States